期刊文献+

胰腺癌Panc-1细胞TFPI-2基因甲基化状态与其体内体外侵袭能力的关系

Effect of 5-Aza-dC on the invasion of human pancreatic cancer cell line in vitro and in vivo and effect of 5-Aza-dC on the expression and methylation of TFPI-2 gene in Panc-1 cell line
下载PDF
导出
摘要 目的:探讨甲基化酶抑制剂5-氮杂-2'-脱氧胞苷(5-aza-2-deoxycytidine,5-Aza-dC)对胰腺癌Panc-1细胞体内体外侵袭能力及裸鼠皮下移植肿瘤组织TFPI-2基因甲基化状态及表达的影响。方法:用不同浓度的5-Aza-dC处理胰腺癌Panc-1细胞。Transwell法测定各组Panc-1细胞的体外侵袭能力。将用药物处理过的各组Panc-1细胞分别接种于裸鼠皮下,观察各组成瘤率及肿瘤大小。用MSP及RT-PCR检测裸鼠移植瘤组织TFPI-2基因甲基化状态及TFPI-2基因mRNA表达情况。结果:与对照组相比,药物处理组Panc-1细胞体外侵袭能力明显下降,裸鼠成瘤率明显降低,第八周时,肿瘤体积明显低于对照组(P<0.05)。与对照组相比,TFPI-2基因异常甲基化状态在药物处理组裸鼠移植瘤组织中得到逆转,药物处理组移植瘤TFPI-2基因mRNA重新表达,并呈剂量依赖性(P<0.05)。结论:甲基化酶抑制剂5-氮杂-2'-脱氧胞苷可能在一定程度上抑制人胰腺癌Panc-1细胞系的体内体外侵袭和生长能力,其机制可能与逆转TFPI-2基因高甲基化状态从而恢复其表达有关。 Objective:To investigate the effects of 5-Aza-2-deoxycytidine(5-Aza-dC) on the invasion of human pancreatic cancer Panc-1 cell line in vitro and vivo,and investigate the effects on the expression and metheylation of TFPI-2 gene in nude mice which loaded human pancreatic cancer cells treated by 5-Aza-dC.Methods: Treated Panc-1 cell line with differernt dosages of 5-Aza-dC.Transwell Chamber method was used to detect the invasion behavior of Panc-1 cell line in vitro after treated with 5-Aza-dC.The Panc-1 cell line treated with different dosages of 5-Aza-dC were implanted into nude mice to observe its growth and metastasis in vivo.TFPI-2 gene DNA,mRNA of carcimoma tissues in nude mice were determined by MSP,RT-PCR.Results: The number of experiment groups to traverse a Matrigel-coated membrane was obviously decreased compared with control group,the invasion ability was lower than control group in vitro.The incidence rate of forming transplantable tumor in experiment group was lower than control group.In eight weeks,the bulk of transplantable tumor in experiment were smaller than control group.The TFPI-2 gene in nude mice carcimoma tissues hypermethylation effectively caused demethylation by 5-Aza-dC.The expression of TFPI-2 mRNA in carcinoma tissues treated with 5-Aza-dC was recovered.Conclusion: 5-Aza-dC could obviously inhibit the invasion ability of pancreatic cancer cells in vitro and in vivo,which may be because 5-Aza-dC reactivates tumor metastasis.
作者 郑浩 汤志刚
出处 《现代肿瘤医学》 CAS 2012年第1期10-13,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:81071734)
关键词 胰腺癌 组织因子途径抑制物-2 5-氮杂-2'-脱氧胞苷 甲基化 pancreatic cancer TFPI-2 5-Aza-dC methylation
  • 相关文献

参考文献11

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics[J].CA Cancer J Clin 2009,59:225-249.
  • 2谢飞,向希映,张吉才,陶建蜀,冯景.RAR-β_2基因启动子异常甲基化与散发性乳腺癌的关系[J].肿瘤防治研究,2011,38(4):408-410. 被引量:4
  • 3Du X,Chand HS,Kisiel W.Human tissue factor pathway inhibitor-2 does not bind or inhibit activated matrix metalloproteinase-1[J].Biochim Biophys Acta,2003,1621(3):242-245.
  • 4Baker AH,Edwards DR,Murphy G.Metalloproteinase inhibitors:biological actions and therapeutic opportunities[J].Cell Sci,2002,115(19):3719-3727.
  • 5Chan AO,Rashid A.CpG island methylation in precursors of gastrointestinal malignancies[J].Curr Mol Med,2006,6:401-408.
  • 6Konduri SD, Srivenugopal KS, Yanamandra N, et al. Promoter methylation and silencing of the tissue factor pathway inhibitor - 2, a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells [ J ]. Oncogene,2003,22 (29) : 4509 - 4516.
  • 7Jones PA.DNA methylation errors and cancer[J].Cancer Res,1996,56:2463-2467.
  • 8Takada H, Wakabayashi N, Dohi O, et al. Tissue factor pathway inhibitor 2 ( TFPI2 ) is frequently silenced by aberrant promoter hypermethylation in gastric cancer [ J ]. Cancer Genet Cytogenet, 2010,197(1) :16 -24.
  • 9Glockner SC,Dhir M,Yi JM,et al.Methylation of TFPI2 in stool DNA:a potential novel biomarker for the detection of colorectal cancer[J].Cancer Res,2009,69(11):4691-4699.
  • 10Tsunoda S,Smith E,De Young NJ,et al.Methylation of CLDN6,FBN2,RBP1,RBP4,TFPI2,and TMEFF2 in esophageal squamous cell carcinoma[J].Oncol Rep,2009,21(4):1067-1073.

二级参考文献13

  • 1Dreger P, Klss M, Petersen B, et al.Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not bone marrow grafts[J].Blood, 1995,86(10):3970-3978.
  • 2Jones PA, Laird PW.Cancer epigentics comes of age[J].Nat Genet,1999,21(2):163-167.
  • 3Jones PA,Takai D.The role of DNA methylation in mammalian epigenetics[J].Science, 2001,293(5532):1068-1070.
  • 4Issa JP.Aging,DNA methylation and cancer[J].Crit Rev Oncol Hematol,1999,32(1):31-43.
  • 5Lund AH, van Lohuizen M.Epigenetics and cancer[J].Genes Dev,2004,18(19):2315-2335.
  • 6Baylin SB, Esteller M, Rountree MR, et al.Aberrant patterns of DNA methylation,chromatin formation and gene expression in cancer[J].Hum Mol Genet,2001,10(7) : 687-692.
  • 7Alvarez S, Germain P, Alvarez R, et al..Structure,function and modulation of retinoic acid receptor beta,a tumor suppressor[J].Int J Biochem Cell Biol,2007,39(7-8): 1406-1415.
  • 8Xu XC.Tumor-suppressive activity of retinoic acid receptor-beta in cancer[J].Cancer lett,2007,253(1):14-24.
  • 9Fontana JA.Interaction of retinoids and tamoxifen on the inhibiton of human mammary carcinoman cell proliferation [J].Exp Cell Boil,1987,55(3):136-144.
  • 10Khodyrev DS, Loginov VI, Pronina IV, et al.Methylation of promoter region of RAR-beta 2 gene in renal cell, breast, and ovarian carcinomas[J].Genetika, 2008,44(8):1126-1132.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部